UNSPSC 85512709: Supplement left external iliac artery with autologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left external iliac artery with autologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 04UJ37Z

UNSPSC 85512709, Supplement left external iliac artery with autologous tissue substitute, percutaneous approach, is a Commodity code that shows a profound mismatch between its nominal scope—a specific vascular surgical procedure—and the actual work state and local governments are soliciting under this tag. The recent opportunities flagged under this code span occupational medical surveillance, pharmacy benefit management, temporary health professional staffing, independent medical evaluation services, specialty surgical networks, and emergency care for youth in custody. None of these categories involves vascular surgery or tissue supplementation. The code appears to be misapplied across heterogeneous health services procurements, suggesting either systematic data-quality issues in the tagging of these solicitations or a classification problem at the point of entry.

The issuing bodies represent a mix of state health agencies, county systems, municipalities, and county-administered pension offices: the Washington State Department of Transportation (occupational health), Collier County Board of County Commissioners (pharmacy benefit management), the County of Santa Clara Health System (temporary staffing), the City of Phoenix Retirement Office (independent medical evaluation), the City of Long Beach (surgical benefit carve-out), and Harris County Juvenile Probation Department (youth detention medical services). Geographic activity spans Washington, California, Florida, Arizona, and Texas. The recent opportunities show no meaningful connection to the code's stated description, and interpreting this code as actionable for vascular surgical procedure sourcing would be misleading. Business development professionals evaluating this code should treat the recent activity as a classification artifact rather than a reliable signal of market demand for the procedure the code nominally describes.